Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP plus botulinum toxin versus PRP alone for knee osteoarthritis
PACTR202109625368648Recruiting
- Sponsor
- Mansoura University Hospital
- Start
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of platelet-rich plasma and neuronox in knee osteoarthritis (OA) (2 arms), sponsored by Mansoura University Hospital. Primary endpoint: Reduction of pain and improvement of function after intraarticular injections. Started Sep 2021; status: recruiting.
02
Drugs
platelet-rich plasmaneuronox
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on PACTR202109625368648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202109625368648.